Eyenovia IncNASDAQ:EYENNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.4866
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.4900/ 87
- Ask / Lots0.5132/ 177
- Open / Previous Close--- / 0.4866
- Day Range---
- 52 Week Range
- Volume26,355
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EYEN |
|---|---|---|
| 09:32 ET | 2334 | 0.51 |
| 09:35 ET | 1130 | 0.51 |
| 09:42 ET | 10300 | 0.5104 |
| 09:44 ET | 5000 | 0.5104 |
| 09:46 ET | 600 | 0.51395 |
| 09:48 ET | 551 | 0.517 |
| 09:51 ET | 390 | 0.5175 |
| 09:57 ET | 100 | 0.513999 |
| 10:00 ET | 3117 | 0.5114 |
| 10:02 ET | 200 | 0.504413 |
| 10:04 ET | 7000 | 0.5041 |
| 10:06 ET | 12400 | 0.5041 |
| 10:08 ET | 12409 | 0.5 |
| 10:09 ET | 9649 | 0.4999 |
| 10:13 ET | 1294 | 0.4999 |
| 10:15 ET | 4980 | 0.4908 |
| 10:18 ET | 2500 | 0.495 |
| 10:22 ET | 1300 | 0.4953 |
| 10:29 ET | 200 | 0.4953 |
| 10:31 ET | 1250 | 0.4912 |
| 10:44 ET | 25000 | 0.4996 |
| 10:47 ET | 400 | 0.497299 |
| 10:49 ET | 7114 | 0.4995 |
| 10:51 ET | 5395 | 0.5024 |
| 10:58 ET | 19685 | 0.5048 |
| 11:00 ET | 100 | 0.502399 |
| 11:03 ET | 12710 | 0.4957 |
| 11:07 ET | 100 | 0.495701 |
| 11:12 ET | 20100 | 0.4997 |
| 11:14 ET | 800 | 0.5 |
| 11:16 ET | 300 | 0.5019 |
| 11:30 ET | 1960 | 0.5005 |
| 11:48 ET | 2400 | 0.504 |
| 11:50 ET | 6160 | 0.50365 |
| 11:52 ET | 100 | 0.5021 |
| 11:56 ET | 300 | 0.5052 |
| 11:59 ET | 2072 | 0.5022 |
| 12:01 ET | 1441 | 0.5021 |
| 12:08 ET | 945 | 0.5021 |
| 12:17 ET | 30480 | 0.4971 |
| 12:19 ET | 1300 | 0.4951 |
| 12:21 ET | 7500 | 0.49415 |
| 12:26 ET | 100 | 0.4912 |
| 12:28 ET | 172 | 0.4971 |
| 12:32 ET | 400 | 0.4971 |
| 12:33 ET | 100 | 0.493 |
| 12:35 ET | 2500 | 0.493 |
| 12:39 ET | 500 | 0.5012 |
| 12:46 ET | 100 | 0.500018 |
| 12:48 ET | 100 | 0.495 |
| 12:51 ET | 100 | 0.495 |
| 12:53 ET | 1100 | 0.495 |
| 12:55 ET | 100 | 0.495 |
| 12:57 ET | 1585 | 0.4957 |
| 01:00 ET | 3575 | 0.4951 |
| 01:02 ET | 4825 | 0.4941 |
| 01:04 ET | 883 | 0.4945 |
| 01:06 ET | 100 | 0.5003 |
| 01:11 ET | 500 | 0.5004 |
| 01:13 ET | 233 | 0.4976 |
| 01:18 ET | 400 | 0.5002 |
| 01:20 ET | 100 | 0.4947 |
| 01:24 ET | 258 | 0.5003 |
| 01:26 ET | 100 | 0.4947 |
| 01:29 ET | 100 | 0.4946 |
| 01:31 ET | 100 | 0.4946 |
| 01:36 ET | 1300 | 0.4999 |
| 01:38 ET | 100 | 0.4946 |
| 01:40 ET | 1160 | 0.4951 |
| 01:42 ET | 100 | 0.495 |
| 01:44 ET | 2200 | 0.495 |
| 01:47 ET | 100 | 0.49695 |
| 01:49 ET | 100 | 0.495 |
| 01:51 ET | 1000 | 0.496 |
| 01:58 ET | 5500 | 0.495 |
| 02:00 ET | 1000 | 0.4951 |
| 02:02 ET | 100 | 0.495 |
| 02:05 ET | 100 | 0.495 |
| 02:09 ET | 100 | 0.495 |
| 02:12 ET | 100 | 0.495 |
| 02:14 ET | 200 | 0.495 |
| 02:16 ET | 100 | 0.495 |
| 02:18 ET | 100 | 0.495 |
| 02:20 ET | 100 | 0.495 |
| 02:21 ET | 100 | 0.495 |
| 02:23 ET | 100 | 0.495 |
| 02:25 ET | 5220 | 0.4946 |
| 02:27 ET | 8761 | 0.4917 |
| 02:30 ET | 5683 | 0.4903 |
| 02:32 ET | 11085 | 0.4902 |
| 02:36 ET | 13418 | 0.4908 |
| 02:41 ET | 500 | 0.494 |
| 02:43 ET | 200 | 0.4911 |
| 02:45 ET | 483 | 0.4911 |
| 02:48 ET | 100 | 0.4911 |
| 02:50 ET | 100 | 0.4911 |
| 02:52 ET | 200 | 0.4918 |
| 02:54 ET | 100 | 0.4924 |
| 02:56 ET | 1100 | 0.4926 |
| 02:57 ET | 100 | 0.4925 |
| 02:59 ET | 200 | 0.493949 |
| 03:01 ET | 900 | 0.4954 |
| 03:06 ET | 100 | 0.4925 |
| 03:08 ET | 100 | 0.4925 |
| 03:10 ET | 3300 | 0.4955 |
| 03:12 ET | 129 | 0.4989 |
| 03:14 ET | 100 | 0.4988 |
| 03:17 ET | 2107 | 0.4989 |
| 03:21 ET | 41767 | 0.49 |
| 03:24 ET | 3770 | 0.4875 |
| 03:28 ET | 600 | 0.4936 |
| 03:33 ET | 4514 | 0.490382 |
| 03:35 ET | 6213 | 0.4884 |
| 03:37 ET | 200 | 0.4883 |
| 03:39 ET | 4190 | 0.4883 |
| 03:42 ET | 900 | 0.4884 |
| 03:44 ET | 4684 | 0.4855 |
| 03:46 ET | 26839 | 0.4931 |
| 03:48 ET | 840 | 0.489693 |
| 03:50 ET | 26325 | 0.4844 |
| 03:51 ET | 500 | 0.4844 |
| 03:53 ET | 3169 | 0.486 |
| 03:55 ET | 5523 | 0.4877 |
| 03:57 ET | 1379 | 0.4858 |
| 04:00 ET | 3412 | 0.4866 |
Yesterday
Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th, from 7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
Oct 23, 2024
Eyenovia Announces Publication of Study Demonstrating Favorable Impact on the Ocular Surface of Medication Delivered with the Optejet(R), from 7:00AM ET on Wednesday Oct 23, 2024 by Dow Jones
7:00AM ET on Wednesday Oct 23, 2024 by Dow Jones
Oct 16, 2024
Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo, from 7:00AM ET on Wednesday Oct 16, 2024 by Dow Jones
7:00AM ET on Wednesday Oct 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Eyenovia Inc | 42.0M | -0.6x | --- |
Lexaria Bioscience Corp | 40.5M | -5.2x | --- |
Odonate Inc | 49.9M | -1,254.8x | --- |
KALA BIO Inc | 31.7M | -0.5x | --- |
PolyPid Ltd | 23.9M | -0.4x | --- |
DH Enchantment Inc | 21.5M | -28.0x | --- |
Company Information
Eyenovia, Inc. is a commercial-stage ophthalmic pharmaceutical technology company developing a pipeline of microdose array print therapeutics based on its Optejet platform. It is focused on the commercialization of Mydcombi (tropicamide+phenylephrine ophthalmic spray) for mydriasis, as well as clobetasol propionate ophthalmic suspension 0.05% to reduce pain and inflammation following ocular surgery. Its product line includes Mydcombi, clobetasol propionate, and therapeutic programs, MicroPine and MicroLine. Mydcombi is its fixed combination formulation of tropicamide-phenylephrine for inducing mydriasis for diagnostic procedures and in conditions where short-term pupil dilation is desired. MicroPine is its topical therapy for the treatment of progressive myopia, a disease associated with pathologic axial elongation of the eye and sclero-retinal stretching. MicroLine is its investigational pharmacologic treatment for presbyopia, a non-preventable, age-related hardening of the lens.
Contact Information
- Headquarters
- 295 Madison Ave Ste 2400NEW YORK, NY, United States 10017
- Phone
- 813-766-9539
- Fax
- 302-636-5454
Executives
- Chairman of the Board, Chief Executive Officer, Chief Medical Officer
- Tsontcho Ianchulev
- Chief Executive Officer, Director
- Michael Rowe
- Chief Financial Officer, Treasurer, Secretary
- Andrew Jones
- Chief Operating Officer
- Bren Kern
- Independent Director
- Michael Geltzeiler
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $42.0M |
|---|---|
Revenue (TTM) | $31.4K |
Shares Outstanding | 86.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.67 |
EPS | $-0.79 |
Book Value | $0.20 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | 1,338.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -114,428.20% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
